Search Results - "Shaffer AL 3rd"

scMagnifier: Resolving fine-grained cell subtypes via GRN-informed perturbations and consensus clustering.

Authors: He, Zhenhui Kangning, Dong

Source: PLoS Computational Biology. 6/18/2026, Vol. 22 Issue 6, p1-22. 22p.

Epstein-barr virus latent membrane protein 1 targets cIAP1, cIAP2 and TRAF2 for proteasomal degradation to activate the non-canonical NF-κB pathway.

Authors: Sun, Yizhe Li, Shunji Mitra, Bidisha et al.

Source: PLoS Pathogens. 1/26/2026, Vol. 22 Issue 1, p1-27. 27p.

Epstein-Barr virus latent membrane protein 1 subverts IMPDH pathways to drive B-cell oncometabolism.

Authors: Burton, Eric M. Maestri, Davide White, Shaowen et al.

Source: PLoS Pathogens. 5/14/2025, Vol. 21 Issue 5, p1-32. 32p.

Prognostic role of Foxp1 and Notch2 immunohistochemistry staining in diffuse large B-cell lymphoma.

Authors: Ghorab, Doaa Abu-Zaiton, Yahia I. Helaly, Ahmed M. et al.

Source: Egyptian Journal of Pathology. Jan-Jun2026, Vol. 46 Issue 1, p16-23. 8p.

This result is not displayed to guests.
Login for full access.

Clinical characteristics and molecular heterogeneity in Follicular lymphoma with extranodal involvement.

Authors: Li, Rui-Chi Tang, Wei Zhang, Hui-Lai et al.

Source: Genome Medicine. 10/24/2025, Vol. 17 Issue 1, p1-15. 15p.

Zanubrutinib, lenalidomide and rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone as initial treatment in non–germinal center B-cell diffuse large B-cell lymphoma: a multi-center phase 2 study by Jiangsu Cooperative Lymphoma Group (JCLG)

Authors: Xia, Yi Miao, Yi Qian, Siqi et al.

Source: BMC Medicine. 10/24/2025, Vol. 23 Issue 1, p1-13. 13p.

RUNX1 expression is regulated by a super-enhancer and is a therapeutic target in adult T-cell leukemia/lymphoma.

Authors: Kobayashi, Yuji Ando, Koji Imaizumi, Yoshitaka et al.

Source: Leukemia & Lymphoma. Dec2024, Vol. 65 Issue 14, p2116-2128. 13p.

Long-term clinical outcomes from the smart start trial: rituximab, lenalidomide and ibrutinib in patients with newly diagnosed large B-cell lymphoma.

Authors: Chohan KL Saul EE Davis RE et al.

Source: Blood cancer journal [Blood Cancer J] 2026 Jul 02; Vol. 16 (1). Date of Electronic Publication: 2026 Jul 02.

Publication Type: Letter

Journal Info: Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101568469 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-5385 (Electronic) Linking ISSN: 20445385 NLM ISO Abbreviation: Blood Cancer J Subsets: MEDLINE; In Process

A novel MIR100HG transcript enhances tumorigenesis by inducing BCLAF1-mediated alternative splicing in colorectal cancer.

Authors: Dai, Mingrui Shi, Yuhua Zhao, Hailin et al.

Source: Cell Communication & Signaling. 7/9/2025, Vol. 23 Issue 1, p1-20. 20p.

Toll-like receptor 9 (TLR9) expression correlates with cell of origin and predicts clinical outcome in diffuse large B-cell lymphoma.

Authors: Own, Sulaf Abd Xagoraris, Ioanna Stathopoulou, Konstantina et al.

Source: BMC Cancer. 5/28/2025, Vol. 25 Issue 1, p1-10. 10p.

The role of non-malignant B cells in malignant hematologic diseases.

Authors: Gao, Daquan¹ (AUTHOR) daquangao2024@163.com

Source: Hematology. Dec2025, Vol. 30 Issue 1, p1-12. 12p.

Multi-omic profiling of follicular lymphoma reveals changes in tissue architecture and enhanced stromal remodeling in high-risk patients.

Authors: Radtke AJ Postovalova E Varlamova A et al.

Source: Cancer cell [Cancer Cell] 2024 Mar 11; Vol. 42 (3), pp. 444-463.e10. Date of Electronic Publication: 2024 Feb 29.

Publication Type: Journal Article

Journal Info: Publisher: Cell Press Country of Publication: United States NLM ID: 101130617 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-3686 (Electronic) Linking ISSN: 15356108 NLM ISO Abbreviation: Cancer Cell Subsets: MEDLINE

The MEK1/2-IRF4 axis fosters T follicular helper cell differentiationand antitumor humoral immune response.

Authors: Ran S Wang S Li R et al.

Source: Journal of translational medicine [J Transl Med] 2026 Mar 16; Vol. 24 (1). Date of Electronic Publication: 2026 Mar 16.

Publication Type: Journal Article

Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 101190741 Publication Model: Electronic Cited Medium: Internet ISSN: 1479-5876 (Electronic) Linking ISSN: 14795876 NLM ISO Abbreviation: J Transl Med Subsets: MEDLINE

Molecular Characterization and Genetic Subclassification Comparison of Diffuse Large B-Cell Lymphoma: Real-Life Experience with 74 Cases.

Authors: Ivanova, Vanesa-Sindi Vela, Visar Dirnhofer, Stefan et al.

Source: Pathobiology. 2024, Vol. 91 Issue 4, p245-253. 9p.

HBZ upregulates myoferlin expression to facilitate HTLV-1 infection.

Authors: Polakowski, Nicholas Sarker, Md Abu Kawsar Hoang, Kimson et al.

Source: PLoS Pathogens. 2/24/2023, Vol. 18 Issue 2, p1-31. 31p.

Interplay between UNG and AID governs intratumoral heterogeneity in mature B cell lymphoma.

Authors: Delgado, Pilar Álvarez-Prado, Ángel F. Marina-Zárate, Ester et al.

Source: PLoS Genetics. 12/23/2020, Vol. 16 Issue 12, p1-23. 23p.

Systems-level identification of key transcription factors in immune cell specification.

Authors: Liu, Cong Omilusik, Kyla Toma, Clara et al.

Source: PLoS Computational Biology. 9/26/2022, Vol. 18 Issue 9, p1-30. 30p. 7 Graphs.

PLK1 inhibition enhances Brentuximab vedotin efficacy in CD30-positive T-cell lymphoma via spindle assembly checkpoint activation.

Authors: Mori Y Suto K Takei N et al.

Source: Leukemia [Leukemia] 2026 Jul 13. Date of Electronic Publication: 2026 Jul 13.

Publication Type: Journal Article

Journal Info: Publisher: Nature Publishing Group, Specialist Journals Country of Publication: England NLM ID: 8704895 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5551 (Electronic) Linking ISSN: 08876924 NLM ISO Abbreviation: Leukemia Subsets: MEDLINE

Targeting of ibrutinib resistance-driving pathways by miR-28 in ABC-DLBCL.

Authors: Álvarez-Corrales E Moreno-Palomares R Gómez-Escolar C et al.

Source: Leukemia [Leukemia] 2026 May; Vol. 40 (5), pp. 894-905. Date of Electronic Publication: 2026 Apr 08.

Publication Type: Journal Article

Journal Info: Publisher: Nature Publishing Group, Specialist Journals Country of Publication: England NLM ID: 8704895 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5551 (Electronic) Linking ISSN: 08876924 NLM ISO Abbreviation: Leukemia Subsets: MEDLINE